Literature DB >> 32015981

Tumor modeling maintains diverse pathology in vitro.

Michael E Bregenzer1, Eric N Horst1, Pooja Mehta2, Caymen M Novak1, Taylor Repetto2, Catherine S Snyder2, Geeta Mehta1,2,3,4,5.   

Abstract

Year:  2019        PMID： 32015981      PMCID： PMC6976448          DOI： 10.21037/atm.2019.12.32

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  8 in total

Review 1.  Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure.

Authors:  Elke Pogge von Strandmann; Silke Reinartz; Uwe Wager; Rolf Müller
Journal:  Trends Cancer       Date:  2017-01-18

2.  Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.

Authors:  Toshiro Sato; Robert G Vries; Hugo J Snippert; Marc van de Wetering; Nick Barker; Daniel E Stange; Johan H van Es; Arie Abo; Pekka Kujala; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2009-03-29       Impact factor: 49.962

3.  An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.

Authors:  Oded Kopper; Chris J de Witte; Kadi Lõhmussaar; Jose Espejo Valle-Inclan; Nizar Hami; Lennart Kester; Anjali Vanita Balgobind; Jeroen Korving; Natalie Proost; Harry Begthel; Lise M van Wijk; Sonia Aristín Revilla; Rebecca Theeuwsen; Marieke van de Ven; Markus J van Roosmalen; Bas Ponsioen; Victor W H Ho; Benjamin G Neel; Tjalling Bosse; Katja N Gaarenstroom; Harry Vrieling; Maaike P G Vreeswijk; Paul J van Diest; Petronella O Witteveen; Trudy Jonges; Johannes L Bos; Alexander van Oudenaarden; Ronald P Zweemer; Hugo J G Snippert; Wigard P Kloosterman; Hans Clevers
Journal:  Nat Med       Date:  2019-04-22       Impact factor: 53.440

Review 4.  Review: Mechanotransduction in ovarian cancer: Shearing into the unknown.

Authors:  Caymen Novak; Eric Horst; Geeta Mehta
Journal:  APL Bioeng       Date:  2018-06-07

Review 5.  Integrated cancer tissue engineering models for precision medicine.

Authors:  Michael E Bregenzer; Eric N Horst; Pooja Mehta; Caymen M Novak; Shreya Raghavan; Catherine S Snyder; Geeta Mehta
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

6.  Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.

Authors:  Raphael Lis; Cyril Touboul; Najeeb M Halabi; Abishek Sainath Madduri; Denis Querleu; Jason Mezey; Joel A Malek; Karsten Suhre; Arash Rafii
Journal:  J Transl Med       Date:  2014-03-05       Impact factor: 5.531

Review 7.  Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.

Authors:  Soochi Kim; Boyun Kim; Yong Sang Song
Journal:  Cancer Sci       Date:  2016-08-16       Impact factor: 6.716

8.  Patient-derived xenografts undergo mouse-specific tumor evolution.

Authors:  Uri Ben-David; Gavin Ha; Yuen-Yi Tseng; Noah F Greenwald; Coyin Oh; Juliann Shih; James M McFarland; Bang Wong; Jesse S Boehm; Rameen Beroukhim; Todd R Golub
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330
  8 in total
  1 in total

Review 1.  First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up.

Authors:  Ziqi Jia; Yanyu Wang; Lei Cao; Yadong Wang; Yang Song; Xiaoying Yang; Zhongxing Bing; Zhili Cao; Peng Liu; Shuyang Zhang; Zexin Chen; Min Huang; Yan Yu; Han Han-Zhang; Jinlei Song; Daniel C Christoph; Antonio Passaro; Cesare Gridelli; Tomoyuki Hishida; Naixin Liang; Shanqing Li
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 3.005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.